BE862089A - NEW 3,20-DIOXY-7ALPHA-HALO-4-PREGNENES AND -1,4-PREGNADIENES AND THEIR PROCESS FOR PREPARATION - Google Patents

NEW 3,20-DIOXY-7ALPHA-HALO-4-PREGNENES AND -1,4-PREGNADIENES AND THEIR PROCESS FOR PREPARATION

Info

Publication number
BE862089A
BE862089A BE183654A BE183654A BE862089A BE 862089 A BE862089 A BE 862089A BE 183654 A BE183654 A BE 183654A BE 183654 A BE183654 A BE 183654A BE 862089 A BE862089 A BE 862089A
Authority
BE
Belgium
Prior art keywords
pregnadienes
pregnenes
7alpha
dioxy
halo
Prior art date
Application number
BE183654A
Other languages
French (fr)
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/753,257 external-priority patent/US4076708A/en
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of BE862089A publication Critical patent/BE862089A/en

Links

Classifications

    • EFIXED CONSTRUCTIONS
    • E04BUILDING
    • E04GSCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
    • E04G11/00Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs
    • E04G11/06Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs for walls, e.g. curved end panels for wall shutterings; filler elements for wall shutterings; shutterings for vertical ducts
    • E04G11/20Movable forms; Movable forms for moulding cylindrical, conical or hyperbolical structures; Templates serving as forms for positioning blocks or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001Lactones
    • C07J21/003Lactones at position 17
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0084Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkylene group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/0026Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • EFIXED CONSTRUCTIONS
    • E04BUILDING
    • E04GSCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
    • E04G17/00Connecting or other auxiliary members for forms, falsework structures, or shutterings
    • E04G17/14Bracing or strutting arrangements for formwalls; Devices for aligning forms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Architecture (AREA)
  • Engineering & Computer Science (AREA)
  • Civil Engineering (AREA)
  • Mechanical Engineering (AREA)
  • Structural Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE183654A 1976-12-22 1977-12-20 NEW 3,20-DIOXY-7ALPHA-HALO-4-PREGNENES AND -1,4-PREGNADIENES AND THEIR PROCESS FOR PREPARATION BE862089A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75325676A 1976-12-22 1976-12-22
US05/753,257 US4076708A (en) 1976-12-22 1976-12-22 Process for the preparation of 7α-halogeno-3-oxo-4-dehydro steroids and novel 7α-halogeno derivatives produced thereby

Publications (1)

Publication Number Publication Date
BE862089A true BE862089A (en) 1978-06-20

Family

ID=27115720

Family Applications (1)

Application Number Title Priority Date Filing Date
BE183654A BE862089A (en) 1976-12-22 1977-12-20 NEW 3,20-DIOXY-7ALPHA-HALO-4-PREGNENES AND -1,4-PREGNADIENES AND THEIR PROCESS FOR PREPARATION

Country Status (20)

Country Link
JP (1) JPS604198B2 (en)
AR (1) AR226806A1 (en)
AT (2) AT373269B (en)
BE (1) BE862089A (en)
DE (1) DE2756550C2 (en)
DK (1) DK153494C (en)
FI (1) FI63947C (en)
FR (1) FR2384793A1 (en)
GB (1) GB1575983A (en)
HK (1) HK584A (en)
HU (1) HU179784B (en)
IE (1) IE45950B1 (en)
IL (1) IL53636A (en)
MY (1) MY8500082A (en)
NL (1) NL180479C (en)
NO (1) NO151826C (en)
NZ (1) NZ186031A (en)
PT (1) PT67432B (en)
SE (1) SE429865B (en)
SG (1) SG58683G (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109680036A (en) 2017-10-02 2019-04-26 爱科来株式会社 The measurement of glycated proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3429926A (en) * 1964-05-25 1969-02-25 Squibb & Sons Inc 7-halo and 6-halo,6-dehydro a-norprogesterones

Also Published As

Publication number Publication date
AR226806A1 (en) 1982-08-31
NZ186031A (en) 1984-07-31
HK584A (en) 1984-01-13
NL7714056A (en) 1978-06-26
FI773825A (en) 1978-06-23
DE2756550A1 (en) 1978-07-06
IE45950L (en) 1978-06-22
IE45950B1 (en) 1983-01-12
DK569977A (en) 1978-09-28
FI63947B (en) 1983-05-31
NO774359L (en) 1978-06-23
JPS5379850A (en) 1978-07-14
PT67432B (en) 1979-05-23
HU179784B (en) 1982-12-28
ATA575980A (en) 1982-04-15
SG58683G (en) 1985-01-11
NO151826B (en) 1985-03-04
SE7714538L (en) 1978-06-23
IL53636A (en) 1983-05-15
DK153494B (en) 1988-07-18
DK153494C (en) 1989-02-20
ATA909477A (en) 1983-05-15
PT67432A (en) 1978-01-01
FI63947C (en) 1983-09-12
NL180479B (en) 1986-10-01
AT377566B (en) 1985-04-10
FR2384793A1 (en) 1978-10-20
FR2384793B1 (en) 1981-11-13
NL180479C (en) 1987-03-02
IL53636A0 (en) 1978-03-10
AT373269B (en) 1984-01-10
MY8500082A (en) 1985-12-31
DE2756550C2 (en) 1986-10-16
GB1575983A (en) 1980-10-01
JPS604198B2 (en) 1985-02-01
SE429865B (en) 1983-10-03
NO151826C (en) 1985-06-12

Similar Documents

Publication Publication Date Title
FR2384753B1 (en) NEW THIOLS AND THEIR PREPARATION PROCESS
BE849794A (en) CARBOSTYRILE DERIVATIVES AND THEIR PREPARATION PROCESS
BE854009A (en) ACRYLAMIDE-STARCHES AND PROCESS FOR THEIR PREPARATION
BE858236A (en) NEW POLYETHERPOLYOLS AND THEIR PREPARATION PROCESS
BE862578A (en) ELECTROCATALYZERS AND PROCESS FOR THEIR PREPARATION
FR2349579A1 (en) 1,2-DIHYDRONAPHTALENE DERIVATIVES AND THEIR PREPARATION PROCESS
MC1174A1 (en) NEW NUCLEOSIDES AND PROCESS FOR THEIR PREPARATION
BE847090A (en) 15-STEROIDS, AND THEIR PREPARATION PROCESS
BE862422A (en) NEW DERIVATIVES OF THE SUCCINIMIDE TYPE AND PROCESS FOR THEIR PREPARATION
OA05565A (en) New 1,2-dithiole derivatives and their preparation process.
OA05566A (en) New 1,2-dithiole derivatives and their preparation process.
BE861503R (en) NEW ISOXAZOLES DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATIONS
BE856220A (en) POLYETHER-POLYUREIDES AND PROCESS FOR THEIR PREPARATION
FR2301528A1 (en) NEW 3-ACYLOXYMETHYL-CEPHEMES COMPOUNDS AND THEIR PREPARATION PROCESS
BE855236A (en) OMEGA-NOR-AROMATIC 13,14-DEHYDRO-PROSTAGLANDIN DERIVATIVES AND PROCESS FOR THEIR PREPARATION
BE858240A (en) NEW BENZOPYRANE DERIVATIVES AND THEIR PREPARATION PROCESS
FR2353537A1 (en) NEW AMINOMETHYLAZOLIC DERIVATIVES, THEIR PREPARATION PROCESS AND THE
FR2317930A1 (en) NEW APOVINCAMINOL DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION
BE851681A (en) 2,9-DIOXATRICYCLO-4,3,03,7- DECANES AND PROCESS FOR THEIR PREPARATION
FR2348189A1 (en) NEW BASIC PARA-BENZOLETHERS AND PROCESS FOR THEIR PREPARATION
FR2341568A1 (en) NEW HOMO-STEROIDS AND THEIR PREPARATION PROCESS
BE848910A (en) NEW CARBAMATE-CARBAMOYL FLUORIDES AND THEIR PREPARATION PROCESS,
BE848627A (en) AMINOBENZALDEHYDES SUBSTITUTE DERIVATIVES AND THEIR PREPARATION PROCESS,
FR2352821A1 (en) NEW THIAZOLORIFAMYCIN DERIVATIVES AND THEIR PREPARATION PROCESS
BE862089A (en) NEW 3,20-DIOXY-7ALPHA-HALO-4-PREGNENES AND -1,4-PREGNADIENES AND THEIR PROCESS FOR PREPARATION

Legal Events

Date Code Title Description
CCPA Application for a supplementary protection certificate

Free format text: 093C0101

CN Change of patent owner's name
CCPV Grant of a supplementary protection certificate

Free format text: 093C0101, EXPIRES 19990405

RE20 Patent expired

Owner name: SCHERING-PLOUGH LTD

Effective date: 19971220